Total Payments
$6,536
2024 Payments
$518.61
Companies
46
Transactions
403
Medicare Patients
4,794
Medicare Billing
$606,228
Payment Breakdown by Category
Food & Beverage$6,531 (99.9%)
Education$5.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,531 | 402 | 99.9% |
| Education | $5.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ORGANOGENESIS INC. | $825.40 | 18 | $0 (2020) |
| Amgen Inc. | $535.71 | 41 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $522.46 | 35 | $0 (2024) |
| Novo Nordisk Inc | $490.87 | 37 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $421.32 | 31 | $0 (2022) |
| Lilly USA, LLC | $291.04 | 21 | $0 (2024) |
| ABBVIE INC. | $282.73 | 21 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $254.60 | 19 | $0 (2024) |
| Mylan Specialty L.P. | $246.11 | 16 | $0 (2024) |
| Merck Sharp & Dohme LLC | $245.54 | 20 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $518.61 | 34 | Novo Nordisk Inc ($72.71) |
| 2023 | $406.47 | 26 | GlaxoSmithKline, LLC. ($69.92) |
| 2022 | $702.96 | 47 | Amgen Inc. ($146.75) |
| 2021 | $561.18 | 43 | Amgen Inc. ($120.13) |
| 2020 | $685.85 | 37 | ORGANOGENESIS INC. ($146.44) |
| 2019 | $1,055 | 63 | Organogenesis Inc. ($224.93) |
| 2018 | $1,440 | 77 | Organogenesis Inc. ($332.65) |
| 2017 | $1,165 | 76 | Allergan Inc. ($128.57) |
All Payment Transactions
403 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/21/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Cardio-renal | ||||||
| 09/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Oncology | ||||||
| 08/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/31/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Diabetes | ||||||
| 06/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: PAIN | ||||||
| 06/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Diabetes | ||||||
| 05/28/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Bone Health | ||||||
| 05/08/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 04/30/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Diabetes | ||||||
| 04/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Diabetes | ||||||
| 04/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Diabetes | ||||||
| 03/22/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Diabetes | ||||||
| 03/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,286 | 2,851 | $352,446 | $165,211 |
| 2022 | 20 | 1,269 | 2,679 | $331,222 | $165,623 |
| 2021 | 15 | 1,116 | 2,569 | $296,513 | $149,187 |
| 2020 | 16 | 1,123 | 2,542 | $295,313 | $126,207 |
Total Patients
4,794
Total Services
10,641
Medicare Billing
$606,228
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 469 | 1,495 | $239,200 | $121,426 | 50.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 138 | 198 | $23,760 | $12,341 | 51.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 25 | 25 | $21,275 | $7,063 | 33.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 63 | 66 | $6,600 | $4,713 | 71.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 19 | 21 | $10,920 | $4,389 | 40.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 24 | 68 | $9,520 | $2,469 | 25.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 61 | 70 | $3,500 | $2,423 | 69.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 64 | 67 | $2,010 | $1,918 | 95.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 78 | 169 | $6,760 | $1,633 | 24.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 37 | 81 | $3,969 | $1,314 | 33.1% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 17 | 35 | $4,025 | $1,047 | 26.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 32 | 32 | $960.00 | $916.16 | 95.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 13 | 25 | $3,750 | $874.56 | 23.3% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 27 | 28 | $2,604 | $848.96 | 32.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 39 | 44 | $1,980 | $712.80 | 36.0% |
| 87807 | Detection test by immunoassay with direct visual observation for respiratory syncytial virus | Office | 2023 | 25 | 27 | $1,566 | $333.84 | 21.3% |
| 90715 | Diphtheria, tetanus, and acellular pertussis vaccine (7 years or older) | Office | 2023 | 11 | 11 | $1,045 | $300.82 | 28.8% |
| 90471 | Administration of vaccine | Office | 2023 | 11 | 11 | $330.00 | $151.10 | 45.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 48 | 64 | $1,280 | $140.80 | 11.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 47 | 118 | $2,260 | $90.87 | 4.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 12 | 64 | $3,648 | $69.63 | 1.9% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 15 | 88 | $1,086 | $30.07 | 2.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 11 | 44 | $398.78 | $4.25 | 1.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 496 | 1,571 | $251,360 | $127,984 | 50.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 149 | 198 | $23,760 | $12,405 | 52.2% |
About Dr. Michael Kelly, MD
Dr. Michael Kelly, MD is a Family Medicine healthcare provider based in Vincennes, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1811972128.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Kelly, MD has received a total of $6,536 in payments from pharmaceutical and medical device companies, with $518.61 received in 2024. These payments were reported across 403 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($6,531).
As a Medicare-enrolled provider, Kelly has provided services to 4,794 Medicare beneficiaries, totaling 10,641 services with total Medicare billing of $606,228. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Vincennes, IN
- Active Since 12/08/2005
- Last Updated 07/21/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1811972128
Products in Payments
- Apligraf (Biological) $413.79
- Apligraf (Device) $265.17
- Otezla (Drug) $250.90
- INVOKANA (Drug) $234.54
- OMNIGRAFT (Device) $231.55
- FARXIGA (Drug) $210.47
- JARDIANCE (Drug) $207.04
- XARELTO (Drug) $186.78
- Livalo (Drug) $174.64
- Ozempic (Drug) $172.52
- Puraply (Medical Supply) $146.44
- EVENITY (Biological) $145.61
- TRULICITY (Drug) $141.96
- Yupelri (Drug) $135.28
- XIFAXAN (Drug) $132.93
- NUEDEXTA (Drug) $126.71
- Victoza (Drug) $120.03
- ENTRESTO (Drug) $114.43
- JANUVIA (Drug) $110.46
- DALVANCE (Drug) $110.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Vincennes
Jane Bridges, M.d, M.D
Family Medicine — Payments: $91,349
Family Medicine $91,349
Dr. Heather Ludwig Akers
Family Medicine — Payments: $8,654
Family Medicine $8,654
Kristin Mahan, Md, MD
Family Medicine — Payments: $5,841
Family Medicine $5,841
Sally Bodensteiner, M.d, M.D
Family Medicine — Payments: $5,342
Family Medicine $5,342
Scott Stine, M.d, M.D
Family Medicine — Payments: $4,513
Family Medicine $4,513
Daniel Herman, M.d, M.D
Family Medicine — Payments: $781.74
Family Medicine $781.74